PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE BEFORE ALLOGENEIC MARROW TRANSPLANTATION IN ACUTE MYELOID LEUKEMIA BY COMBINEDWT1 EXPRESSION LEVELS AND FLOW CYTOMETRY ASSESMENT

EHA Library, Fabio Guolo, 54161

VALIDATION OF SIE/SIES/GITMO 'FITNESS CRITERIA' FOR ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA: APPLICABILITY AND OUTCOME ANALYSIS ACCORDING TO FITNESS AND TO TREATMENT RECEIVED.

EHA Library, Erika BORLENGHI, 54162

Allogeneic hematopoietic stem cell transplantation for patients with core-binding-factor acute myeloid leukemia with c-KIT mutations

EHA Library, Linkun Lee, 54163

ADVERSE PROGNOSTIC IMPACT OF IDH MUTATIONS ON OUTCOME IN ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE

EHA Library, Marijana Virijevic, 54164

ROLE OF INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS: KOREAN SOCIETY OF HEMATOLOGY AML/MDS WORKING PARTY KAMS0119 STUDY

EHA Library, Soo-Jeong Kim, 54165

COMBINED USE OF MULTI-COLOR FCM AND PCR ANALYSIS CAN DETECT LESS THAN 0.01% PATHOLOGICAL CELLS IN THE VAST MAJORITY OF DE NOVO AML CASES

EHA Library, Yasuhiro Kazuma, 54166

INDOLEAMINE 2,3-DIOXYGENASE-1 (IDO-1) IS ASSOCIATED WITH HIGH INCIDENCE OF CHEMOREFRACTORY DISEASE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS

EHA Library, Sarah Parisi, 54167

INTEREST OF CYTOGENETIC AND FISH EVALUATION FOR PROGNOSIS EVALUATION IN 198 PATIENTS WITH ACUTE MYELOID LEUKEMIA IN FIRST COMPLETE REMISSION IN A SINGLE INSTITUTION

EHA Library, Pierre Hirsch, 54169

ACUTE MYELOID LEUKEMIA IN PATIENTS OLDER THAN 75: PROGNOSTIC IMPACT OF FLT3-ITD AND NPM1 MUTATIONS

EHA Library, Pierre Hirsch, 54170

MOLECULAR RELEVANCE OF THE NERVE GROWTH FACTOR RECEPTOR GENE (NTRK1) EXPRESSION IN AML-RELATED MYELOID SARCOMA

EHA Library, Francesca Lazzaroni, 54171

ELN FAVORABLE ACUTE MYELOID LEUKEMIA SHARE THE SAME GOOD PROGNOSIS ACROSS CYTOGENETIC/MOLECULAR SUBGROUPS: PRELIMINARY RETROSPECTIVE REAL-LIFE ANALYSIS OF THE RETE EMATOLOGICA LOMBARDA (REL)

EHA Library, Patrizia Zappasodi, 54172

A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS

EHA Library, Dario Ferrero, 54173

MDRO INFECTION THE ‘'MAJOR HURDLE TO ACUTE MYELOID LEUKEMIA INDUCTION THERAPY' EXPERIENCE OF A TERTIARY CARE COMPREHENSIVE CANCER CENTER FROM INDIA.

EHA Library, Anupam Chakrapani, 54174

ACQUIRED IDH1 AND IDH2 MUTATIONS IN CYTOGENETICALLY NORMAL ACUTE MYELOID LEUKAEMIA: THEIR PREVALENCE AND ASSOCIATION WITH OTHER GENE MUTATIONS – A SINGLE CENTRE EXPERIENCE

EHA Library, Gee Fung How, 54175

CLINICAL USEFULNESS OF WT1 MRNA EXPRESSION IN BONE MARROW DETECTED USING A NEW WT1 MRNA ASSAY KIT FOR MONITORING ACUTE MYELOID LEUKEMIA: A COMPARISON WITH PERIPHERAL BLOOD WT1 MRNA EXPRESSIONS

EHA Library, Ken Ishiyama, 54176

MENINGIOMA 1 (MN1) EXPRESSION: REFINED RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS

EHA Library, lamia Ibrahem, 54177

TIME FROM DIAGNOSIS TO TREATMENT (TDT) INITIATION AFFECTS PROGNOSIS OF ACUTE MYELOID LEUKEMIA (AML) IN YOUNGER ADULTS

EHA Library, Juliana Schuh, 54179

THE IMPACT OF MOLECULAR MINIMAL RESIDUAL DISEASE MONITORING IN PEDIATRIC PATIENTS WITH CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA ENROLLED IN THE AIEOP AML 2002/01 PROTOCOL.

EHA Library, Martina Pigazzi, 54180

NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS CAN BENEFIT FROM A SIGNIFICANT BETTER SURVIVAL WHEN INCLUDED IN CLINICAL TRIALS

EHA Library, Mauricette Michallet, 54181

COMPARATIVE ANALYSIS OF FOUR COURSES OF STANDARD-DOSE CONSOLIDATION WITHOUT MAINTENANCE VERSUS THREE COURSES OF LOW-INTENSITY CONSOLIDATION WITH MAINTENANCE IN ADULTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Sergey Semochkin, 54183

MN1 OVEREXPRESSION IS A POWERFUL PREDICTOR OF FAILURE OF INDUCTION CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIAS SUCH AS CONVENTIONAL CYTOGENETICS AND AGE.

EHA Library, Carlos Rodríguez, 54184

A PHENOTYPIC STUDY OF MONOCLONAL B-CELL LYMPHOCYTOSIS, WITH EMPHASIS ON BIPHENOTYPIC CASES

EHA Library, Ioannis Kostopoulos, 54185

TARGETED ARRAYCGH USED FOR DETERMINING MINIMALLY DELETED REGION ON CHROMOSOME 6Q IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Marie Jarosova, 54186

INCORPORATION OF NEXT-GENERATION SEQUENCING INTO ATM GENE ANALYSIS IN PATIENTS WITH CLL AND MCL

EHA Library, Veronika Navrkalova, 54187

NOD/SCID GAMMA XENOGRAFT MODEL OF B-CELL MALIGNANCIES USING TP53- AND/OR ATM-DEFICIENT CELL LINES

EHA Library, Jan Verner, 54188

COPY NUMBER ALTERATIONS AND NOTCH1 MUTATIONS PREDICT THE OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA AND NORMAL FISH

EHA Library, Julio Delgado, 54189

CYTOGENETIC EVOLUTION PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, MICHAIL IKSAS, 54193

CHARACTERIZATION AND SIGNIFICANCE OF RARE BALANCED IMMUNOGLOBULIN TRANSLOCATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Florence Van Obbergh, 54194

IMPACT OF TWO CYTOGENETIC LESIONS ON THE OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Andrea Visentin, 54195

SYSTEMATIC DRUG SENSITIVITY SCREENING IN LYMPHOID MALIGNANCIES IDENTIFIES VULNERABILITIES OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH HIGH RISK ABERRATIONS

EHA Library, Leopold Sellner, 54197

TRISOMY 12 IS ASSOCIATED WITH A DISTINCT PATTERN OF LYMPHOCYTOSIS DURING TREATMENT OF CLL WITH IBRUTINIB, WHICH DOES NOT AFFECT RESPONSE DEPTH OR DURATION

EHA Library, Philip Thompson, 54198

INTEGRATION OF NOVEL GENE MUTATIONS INTO KARYOTYPE-BASED SUBGROUPS AS A PROGNOSTIC RISK STRATIFICATION TOOL IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ilaria Del Giudice, 54199

CD4+CD16- LGL LEUKEMIA SHOWS DISTINCTIVE BIOLOGICAL AND CLINICAL FEATURES

EHA Library, Gregorio Barilà, 54200

DEVELOPMENT AND VALIDATION OF A NOTCH CUSTOM NGS ASSAY FOR IDENTIFYING NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER LYMPHOID MALIGNANCIES

EHA Library, Hsiang-I Liao, 54201

ITALIAN VALIDATION OF THE MDACC PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: ANALYSIS OF 1502 CASES.

EHA Library, Massimo Gentile, 54202

FLUDARABINE, CYCLOPHOSPHAMIDE AND LENALIDOMIDE IN RELAPSED/REFRACTORY PATIENTS WITH CLL, PRELIMINARY RESULTS OF THE PHASE1-2 GIMEMA CLL0606 STUDY.

EHA Library, Francesca Romana Mauro, 54203

A POPULATION BASED EXPERIENCE ON THE USE OF RCD OR RCVP IN AUTOIMMUNE HEMOLYTIC ANEMIA IN CLL

EHA Library, Rajat Kumar, 54205

IMPROVING SURVIVAL IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA OVER A 40-YEAR PERIOD (1971-2011): A SINGLE INSTITUTION EXPERIENCE

EHA Library, Stefano Molica, 54207

REDUCTION OF TUMOR LYSIS SYNDROME (TLS) RISK IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS TREATED WITH ABT-199 (GDC-0199): RESULTS OF MODIFICATIONS TO DOSING SCHEDULE AND TLS PROPHYLAXIS

EHA Library, John Seymour, 54208

OPEN LABEL MULTICENTER STUDY OF ELTROMBOPAG FOR THE TREATMENT OF IMMUNE THROMBOCYTOPENIA SECONDARY TO LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Carlo Visco, 54209

IS ZAP-70 STILL A KEY PROGNOSTIC FACTOR IN EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA? RESULTS OF THE ANALYSIS FROM A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY

EHA Library, Massimo Gentile, 54210

EVALUATION OF IMMUNE RESPONSE TO 13-VALENT PNEUMOCOCCAL CONJUGATED VACCINE (PCV13) IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA

EHA Library, Jacek Rolinski, 54211

INITIAL CHARACTERISTICS, TREATMENT AND PROGNOSIS ACCORDING TO AGE IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A SINGLE-CENTER ANALYSIS BASED ON 949 PATIENTS.

EHA Library, Tycho Baumann, 54212

COMPARATIVE EFFECT OF BENDAMUSTINE PLUS RITUXIMAB (R) VS FLUDARABINE PLUS CYCLOPHOSPHAMIDE PLUS R ON THE LEVELS OF PERIPHERAL BLOOD LEUCOCYTE POPULATIONS IN ADVANCED-STAGE CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Susana Barrena, 54214

EFFICACY AND SAFETY OF BENDAMUSTINE IN COMBINATION WITH RITUXIMAB FOR ELDERLY PATIENTS WITH PREVIOUSLY UNTREATED B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA. AN ITALIAN RETROSPECTIVE MULTICENTER STUDY.

EHA Library, Luca Laurenti, 54215

ANALYSIS OF MERKEL CELL POLYOMAVIRUS PROGNOSTIC SIGNIFICANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Michael Doubek, 54217

A PATHOLOGICAL ABDOMINAL ULTRASONOGRAPHY AT DIAGNOSIS OF CLL SIGNIFICANTLY REDUCES THE TIME TO PROGRESSION IN PATIENTS WITH RAI 0 OR 1 DISEASE

EHA Library, Sara Pezzatti, 54218

IN VITRO COMPARATIVE STUDY ON DIRECT KILLING OF CLL CELLS BY SMALL TARGETED THERAPEUTIC MOLECULES

EHA Library, Sandra Eketorp Sylvan, 54219

DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE 'WARNING' RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?

EHA Library, Valentin Garcia-Gutierrez, 54221

SENSOR INTERIM DATA WITH MUTATION ANALYSIS: SWITCHING TO NILOTINIB AFTER MOLECULAR SUBOPTIMAL RESPONSE TO IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

EHA Library, Kazuhito Yamamoto, 54222

TYROSINE KINASE INHIBITOR (TKI) SWITCHING: EXPERIENCE FROM SIMPLICITY, A PROSPECTIVE OBSERVATIONAL STUDY OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS IN CLINICAL PRACTICE

EHA Library, Rüdiger Hehlmann, 54223

DASATINIB PHARMACOKINETICS AND ITS CORRELATION WITH CLINICAL RESPONSE IN CHRONIC MYELOID LEUKEMIA: A SUBANALYSIS OF THE DARIA-01 STUDY

EHA Library, Kotaro Miyao, 54225

LONG-TERM FOLLOW-UP OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN COMPLETE MOLECULAR RESPONSE WITH ALPHA-INTERFERON AFTER TREATMENT DISCONTINUATION

EHA Library, Roberto Latagliata, 54226

FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE

EHA Library, Ahmet Emre Eskazan, 54227

LONG-TERM RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL OF HIGH-DOSE IMATINIB WITH OR WITHOUT INTERFERON-α IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE

EHA Library, Koji Sasaki, 54228

FOUR-YEAR FOLLOW-UP OF PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA RECEIVING DASATINIB: EFFICACY AND SAFETY

EHA Library, Xiaojun Huang, 54229

ABNORMALITY OF GLUCOSE AND LIPID METABOLISM DURING NILOTINIB THERAPY – RESULTS OF ENIGMA 2 STUDY

EHA Library, Lukas Semerad, 54230

Higher Rate of Major Molecular Response With Nilotinib vs Imatinib in Chinese Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTchina 24-Month Update

EHA Library, Zhi-Xiang Shen, 54231

A NATIONAL EXPERIENCE OF THE USE OF PONATINIB IN PATIENTS FAILING MULTIPLE TYROSINE KINASE INHIBITORS CONFIRMS EFFICACY IN A HEAVILY PRE-TREATED COHORT OF PATIENTS WITH PH+ LEUKAEMIAS

EHA Library, Gareth Gerrard, 54236

OUTCOMES OF THIRD-LINE BCR-ABL1 TYROSINE KINASE INHIBITORS IN THE TREATMENT FAILED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WHO HAVE RECEIVED TWO PRIOR TKIS

EHA Library, Sung-Eun Lee, 54237

PREDICTIVE FACTORS FOR OUTCOME TO NOVEL BCR-ABL1 TYROSINE KINASE INHIBITORS IN IMATINIB FAILED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Sung-Eun Lee, 54238

OUTCOMES OF PREGNANCY AND THERAPEUTIC APPROACHES IN CHRONIC MYELOID LEUKEMIA DURING PREGNANCY

EHA Library, Ekaterina Chelysheva, 54239

LONG-TERM EVALUATION OF VASCULAR TOXICITY IN PATIENTS WITH PH+ LEUKEMIAS TREATED WITH BOSUTINIB

EHA Library, Kristen McGrory, 54240

CHROMOSOMAL ABNORMALITIES IN PHILADELPHIA CHROMOSOME (PH)-NEGATIVE METAPHASES IN NEWLY DIAGNOSED PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE TREATED FRONTLINE WITH NILOTINIB OR DASATINIB

EHA Library, Shilpan Shah, 54241

CLINICAL EXPERIENCE OF BOSUTINIB UNDER COMPASIONATE USE PROGRAM IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH RESISTANCE OR INTOLERANCE TO IMATINIB, DASATINIB AND NILOTINIB

EHA Library, Valentin Garcia-Gutierrez, 54242

LONG-TERM ASSESSMENT OF CARDIAC TOXICITY IN PATIENTS WITH PH+ LEUKEMIAS TREATED WITH BOSUTINIB

EHA Library, Kristen McGrory, 54243

DESIGN OF RAPID FLUORESCENT MOLECULAR BEACON BASED PCR ASSAY FOR DETECTION AND QUANTIFICATION OF BCR –ABL TRANSCRIPTS IN CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Sunita Jetly, 54244

HYPOPHOSPHATEMIA AS A PREDICTOR OF RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML) TREATED WITH IMATINIB

EHA Library, Teresa Garrido, 54245

Risk and Impact of Tuberculosis in Patients with Chronic Myeloid Leukemia: A Nationwide Population-Based Study in Taiwan

EHA Library, Chia-Jen Liu, 54246

MULTICENTER CLINICAL STUDY TO EVALUATE A UTILITY OF FRET-BASED DRUG SENRITIVITY TEST THAT PREDICTS EARLY MOLECULAR RESPONSE IN NEWLY DIAGNOSED CML PATIENTS TREATED WITH NILOTINIB

EHA Library, Takeshi Kondo, 54247

FIRST PRELIMINARY REPORT OF ARAB LEUKEMIA NET (ALN) REGISTRY FOR CHRONIC MYELOID LEUKAEMIA (CML) IN THE MIDDLE EAST &NORTH AFRICA REGION.PART I EPIDEMIOLOGY OF CML IN EGYPT.

EHA Library, Mohamed Azzazi, 54248

UPDATED REPORT OF THE AUSTRIAN CML REGISTRY

EHA Library, Stefan Schmidt, 54249

10 YEARS' EXPERIENCE OF TYROSINE KINASE INHIBITOR THERAPY FOR CML IN A SINGLE UK CENTRE: COMPARISON WITH PRE-TKI ERA AND EVALUATION OF 2013 ELN GUIDELINES

EHA Library, Dalia Khan, 54250

THE EFFECT OF DELAYED TKI TREATMENT ON CYTOGENETIC AND MOLECULAR RESPONSES IN CML PATIENTS: 8 YEAR FOLLOW-UP STUDY IN BOSNIA

EHA Library, Azra Kurtovic, 54253

BCR-ABL1 KINASE DOMAIN MUTATION ANALYSIS USING AMPLICON DEEP SEQUENCING ON THE ION TORRENT PLATFORM

EHA Library, Hui En Foong, 54255

THE INFLUENCE OF DISEASE AND COMORBIDITY RISK ASSESSMENTS ON THE SURVIVAL OF MDS PATIENTS TREATED WITH 5-AZACITIDINE

EHA Library, Alfredo Molteni, 54256

IRON-CHELATING THERAPY WITH DEFERASIROX IN HIGHER RISK MYELODYSPLASTIC SYNDROMES: A RETROSPECTIVE, MULTICENTER, ITALIAN STUDY

EHA Library, Pellegrino Musto, 54257

PROGNOSTIC IMPLICATION OF IPSS AND IPSS-R FOR PATIENTS WITH LOWER-RISK MDS TREATED WITH HYPOMETHYLATING AGENTS

EHA Library, Joon Ho MOON, 54259

HIGHER BONE MARROW LGALS3 EXPRESSION PREDICTS FAVORABLE PROGNOSIS IN ADULT PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Hsin-An Hou, 54260

VALUE OF THE MULTIPARAMETRIC FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA UNDER HYPOMETHYLATING AGENT THERAPY.

EHA Library, Marcelo Iastrebner, 54261

CLINICAL VALUE OF MONOSOMAL KARYOTYPE AND COMPLEX KARYOTYPE AS PROGNOSTIC PARAMETER IN PATIENTS WITH IPSS INTERMEDIATE-2 AND HIGH RISK MYELODYSPLASTIC SYNDROMES TREATED WITH AZACITIDINE

EHA Library, Moo-Kon Song, 54262

COEXPRESSION OF CD7 AND LINEAGE INFIDELITY MARKERS ON MYELOID PRECURSORS CORRELATES WITH RESPONSE TO AZACITIDINE IN IPSS HIGH RISK MDS PATIENTS

EHA Library, Elisa Cannizzo, 54263

IMPACT OF GRAFT-VERSUS-HOST DISEASE ON OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR LOW-RISK MYELODYSPLASTIC SYNDROMES

EHA Library, Jun Aoki, 54265

IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC TRASPLANT

EHA Library, María Díez Campelo, 54266

COMBINED ASSESSMENT OF WT1 AND BAALC EXPRESSION LEVELS IMPROVES RISK STRATIFICATION IN MYELODYSPLASTIC SYNDROMES

EHA Library, Paola Minetto, 54268

IMPACT OF HIGH-DOSE RADIATION EXPOSURE ON NAGASAKI ATOMIC BOMB SURVIVORS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH AZACITIDINE

EHA Library, Tatsuro Jo, 54269

TREG CELLS NUMBER FROM HIGH-RISK MYELODISPLASTIC SYNDROME PATIENTS IS INCREASE, BUT ITS SUPRESSION HABILITY IS IMPARED

EHA Library, Aline Perazzio, 54270

METHYLATION PATTERNS IN PATIENTS WITH HIGH-RISK MYELODYSPLASTIC SINDROMES AND SECONDARY ACUTE MYELOID LEUKEMIA TREATED WITH HIPOMETHYLANT AGENTS (HIGH-RISK MDS 2009 PROTOCOL OF CETLAM GROUP).

EHA Library, Marta Cabezón, 54271

HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumour microenvironment

EHA Library, Enrica Borsi, 54272

PROTEASOME INHIBITORS MODULATE OSTEOCYTE DEATH AND AUTOPHAGY IN MULTIPLE MYELOMA.

EHA Library, Nicola Giuliani, 54276

THE METABOLIC STRESS INDUCED BY CYCLIN D1 IMPACTS CELL ADHESION, MIGRATION AND CELL ADHESION-MEDIATED DRUG RESISTANCE (CAM-DR) IN MYELOMA CELLS.

EHA Library, Sophie Bustany, 54277

CYCLIN D1 CONSTITUTIVE EXPRESSION SENSITIZES MULTIPLE MYELOMA CELLS TO BORTEZOMIB BY INHIBITING HEAT SHOCK PROTEINS.

EHA Library, Sophie Bustany, 54278

SERUM LEVELS OF DICKKOPF-1 PREDICT PROGRESSION FREE SURVIVAL IN MULTIPLE MYELOMA PATIENTS TREATED WITH AUTOLOGOUS STEM CELL TRANSPLANTAT BUT ITS PROGNOSTIC VALUE IS OVERCOME BY THE USE OF NOVEL DRUGS

EHA Library, Jiri Minarik, 54279

IMPACT OF EXONIZED ALUS ON SOLUBLE RANKL MRNA TRANSLATIONAL DYNAMICS.

EHA Library, Emmanouil Spanoudakis, 54280

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β- Catenin Signaling Pathway

EHA Library, Zhen Cai, 54281

PRECLINICAL ANTIMYELOMA ACTIVITY OF THE ALKYLATING-HDACI FUSION MOLECULE EDO-S101 THROUGH DNA-DAMAGING AND HDACI EFFECTS

EHA Library, Ana-Alicia López-Iglesias, 54282

CHARACTERIZATION OF SERUM AND GLUCOCORTICOID-INDUCIBLE KINASE 3 (SGK-3) AS A POTENTIAL ONCOGENIC ALTERNATIVE TO SIGNALLING VIA AKT IN MULTIPLE MYELOMA

EHA Library, Maria-Elisabeth Goebeler, 54285